Other Stories

Gilead inks deals with generics drugmakers to supply remdesivir for 127 countries Updated: 2020-05-13 17:19:16 KST

American biopharmaceutical company Gilead Sciences has inked a deal with Indian and Pakistani generics drugmakers to manufacture and distribute the potential COVID-19 treatment remdesivir in 127 countries.
Five drug manufacturers will make remdesivir primarily for distribution in low-income countries as well as several other countries that face healthcare obstacles amid the coronavirus pandemic.
Countries that will be able to receive the drugs include North Korea, Afghanistan and South Africa.
The deal will be royalty-free until the WHO says the outbreak is no longer a global health crisis or until a pharmaceutical product other than remdesivir is proven effective at treating or preventing COVID-19.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.